Terms: = Bone cancer AND CIITA, P33076, 4261, ENSG00000179583, MHC2TA, C2TA
16 results:
1. Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses.
Chan KL; Gomez J; Cardinez C; Kumari N; Sparbier CE; Lam EYN; Yeung MM; Garciaz S; Kuzich JA; Ong DM; Brown FC; Chan YC; Vassiliadis D; Wainwright EN; Motazedian A; Gillespie A; Fennell KA; Lai J; House IG; Macpherson L; Ang CS; Dawson SJ; Beavis PA; Wei AH; Burr ML; Dawson MA
Cancer Cell; 2022 Oct; 40(10):1190-1206.e9. PubMed ID: 36179686
[TBL] [Abstract] [Full Text] [Related]
2. Osteocyte ciita aggravates osteolytic bone lesions in myeloma.
Liu H; He J; Bagheri-Yarmand R; Li Z; Liu R; Wang Z; Bach DH; Huang YH; Lin P; Guise TA; Gagel RF; Yang J
Nat Commun; 2022 Jun; 13(1):3684. PubMed ID: 35760800
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptional Plasticity Drives Leukemia Immune Escape.
Eagle K; Harada T; Kalfon J; Perez MW; Heshmati Y; Ewers J; Koren JV; Dempster JM; Kugener G; Paralkar VR; Lin CY; Dharia NV; Stegmaier K; Orkin SH; Pimkin M
Blood Cancer Discov; 2022 Sep; 3(5):394-409. PubMed ID: 35709529
[TBL] [Abstract] [Full Text] [Related]
4. Decoding the role of macrophages in periodontitis and type 2 diabetes using single-cell RNA-sequencing.
Agrafioti P; Morin-Baxter J; Tanagala KKK; Dubey S; Sims P; Lalla E; Momen-Heravi F
FASEB J; 2022 Feb; 36(2):e22136. PubMed ID: 35032412
[TBL] [Abstract] [Full Text] [Related]
5. Screening of osteoarthritis diagnostic markers based on immune-related genes and immune infiltration.
Yuan WH; Xie QQ; Wang KP; Shen W; Feng XF; Liu Z; Shi JT; Zhang XB; Zhang K; Deng YJ; Zhou HY
Sci Rep; 2021 Mar; 11(1):7032. PubMed ID: 33782454
[TBL] [Abstract] [Full Text] [Related]
6. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.
Toffalori C; Zito L; Gambacorta V; Riba M; Oliveira G; Bucci G; Barcella M; Spinelli O; Greco R; Crucitti L; Cieri N; Noviello M; Manfredi F; Montaldo E; Ostuni R; Naldini MM; Gentner B; Waterhouse M; Zeiser R; Finke J; Hanoun M; Beelen DW; Gojo I; Luznik L; Onozawa M; Teshima T; Devillier R; Blaise D; Halkes CJM; Griffioen M; Carrabba MG; Bernardi M; Peccatori J; Barlassina C; Stupka E; Lazarevic D; Tonon G; Rambaldi A; Cittaro D; Bonini C; Fleischhauer K; Ciceri F; Vago L
Nat Med; 2019 Apr; 25(4):603-611. PubMed ID: 30911134
[TBL] [Abstract] [Full Text] [Related]
7. Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.
Shah N; Mohammad AS; Saralkar P; Sprowls SA; Vickers SD; John D; Tallman RM; Lucke-Wold BP; Jarrell KE; Pinti M; Nolan RL; Lockman PR
Pharmacol Res; 2018 Jun; 132():47-68. PubMed ID: 29604436
[TBL] [Abstract] [Full Text] [Related]
8. [Treating cancer-related Fatigue after Chemotherapy in Lung cancer Patients by Yiqi Jianpi Recipe: a Clinical Study].
Wang X; You J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Sep; 35(9):1069-73. PubMed ID: 26591361
[TBL] [Abstract] [Full Text] [Related]
9. Digital fibromyxoma (superficial acral fibromyxoma): a detailed characterization of 124 cases.
Hollmann TJ; Bovée JV; Fletcher CD
Am J Surg Pathol; 2012 Jun; 36(6):789-98. PubMed ID: 22367301
[TBL] [Abstract] [Full Text] [Related]
10. The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma.
Steiner T; Kirchner H; Siebels M; Doehn C; Heynemann H; Varga Z; Rohde D; Schubert J; Jocham D; Stief C; Fornara P; Hofmann R; Loening S; Roigas J
J Cancer Res Clin Oncol; 2010 Jun; 136(6):905-10. PubMed ID: 20012752
[TBL] [Abstract] [Full Text] [Related]
11. Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates ciita pIV in cooperation with IFN-gamma.
Ito T; Nishiyama C; Nakano N; Nishiyama M; Usui Y; Takeda K; Kanada S; Fukuyama K; Akiba H; Tokura T; Hara M; Tsuboi R; Ogawa H; Okumura K
Int Immunol; 2009 Jul; 21(7):803-16. PubMed ID: 19502584
[TBL] [Abstract] [Full Text] [Related]
12. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
[TBL] [Abstract] [Full Text] [Related]
13. Interferon-gamma-induced suppression of S100A4 transcription is mediated by the class II transactivator.
Boye K; Andersen K; Tveito S; Øyjord T; Maelandsmo GM
Tumour Biol; 2007; 28(1):27-35. PubMed ID: 17143014
[TBL] [Abstract] [Full Text] [Related]
14. Negative regulation of MHC class II gene expression by CXCR4.
Sheridan C; Sadaria M; Bhat-Nakshatri P; Goulet R; Edenberg HJ; McCarthy BP; Chang CH; Srour EF; Nakshatri H
Exp Hematol; 2006 Aug; 34(8):1085-92. PubMed ID: 16863915
[TBL] [Abstract] [Full Text] [Related]
15. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
Broxmeyer HE; Cooper S; Hangoc G; Chang CH
Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
[TBL] [Abstract] [Full Text] [Related]
16. High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation.
Passweg JR; Meyer-Monard S; Gregor M; Favre G; Heim D; Ebnoether M; Tichelli A; Gratwohl A
Bone Marrow Transplant; 2002 Sep; 30(5):267-71. PubMed ID: 12209347
[TBL] [Abstract] [Full Text] [Related]